Search

Author/Creator Qiu, Ruolun

1. [O2–09–05]: SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF PF‐06751979, A POTENT AND SELECTIVE ORAL BACE1 INHIBITOR: RESULTS FROM PHASE1 SINGLE AND MULTIPLE ASCENDING DOSE STUDIES IN HEALTHY YOUNG AND OLDER VOLUNTEERS. (1st July 2017)

Authors:
Qiu, Ruolun; Liu, Richann; He, Ping; Wills, Anne‐Marie; Tankisheva, Ekaterina; Alvey, Christine; Buckeridge, Clare; Bednar, Martin; Alexander, Robert C.; Chen, Danny
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 11
Page Start:
P575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. [O2–17–04]: PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) EFFECTS OF PF‐06648671, A NOVEL GAMMA SECRETASE MODULATOR (GSM), FOLLOWING SINGLE AND MULTIPLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS. (1st July 2017)

Authors:
Ahn, Jae Eun; Liu, Richann; Trapa, Patrick; Wood, Kathleen M.; Hajos‐Korcsok, Eva; Fullerton, Terence; Qiu, Ruolun
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 12
Page Start:
P601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 2a, randomized, double‐blind, placebo‐controlled, three‐arm, parallel‐group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF‐06835919 in patients with non‐alcoholic fatty liver disease and type 2 diabetes. Issue 4 (17th January 2023)

Authors:
Saxena, Aditi R.; Lyle, Stephanie‐An; Khavandi, Kaivan; Qiu, Ruolun; Whitlock, Mark; Esler, William P.; Kim, Albert M.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 4(2023)
Page Start:
992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P2‐009: PF‐06648671–A Novel Gamma Secretase Modulator: Safety, Tolerability, Pharmacokinetics, and Effects on Plasma Amyloid‐B Levels Following Single Oral Ascending Doses in Healthy Volunteers. (1st July 2016)

Authors:
Qiu, Ruolun; Liu, Richann; Wills, Anne-Marie; He, Ping; Leurent, Claire; Hajos-Korcsok, Eva; Mendes da Costa, Laure; Alexander, Robert C.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 12
Page Start:
P611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies. Issue 1 (11th September 2019)

Authors:
Ahn, Jae Eun; Carrieri, Charles; Dela Cruz, Fernando; Fullerton, Terence; Hajos‐Korcsok, Eva; He, Ping; Kantaridis, Constantino; Leurent, Claire; Liu, Richann; Mancuso, Jessica; Mendes da Costa, Laure; Qiu, Ruolun
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 107:Issue 1(2020)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF‐06372865. (18th January 2018)

Authors:
Nickolls, Sarah A; Gurrell, Rachel; van Amerongen, Guido; Kammonen, Juha; Cao, Lishuang; Brown, Adam R; Stead, Clara; Mead, Andy; Watson, Christine; Hsu, Cathleen; Owen, Robert M; Pike, Andy; Fish, Rebecca L; Chen, Laigao; Qiu, Ruolun; Morris, Evan D; Feng, Gang; Whitlock, Mark; Gorman, Donal; va...
Journal:
British journal of pharmacology
Issue:
Volume 175:Number 4(2018)
Page Start:
708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗